European Commission Greenlights Expanded HIV-1 Treatment for Children with EDURANT®
The European Commission approved the use of EDURANT® (rilpivirine) for pediatric HIV-1 treatment across the EU. This decision offers a new, targeted therapy for younger […]
European Commission Greenlights Expanded HIV-1 Treatment for Children with EDURANT® Read More »